Literature DB >> 8550843

The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

Y Weinrauch1, P Elsbach, L M Madsen, A Foreman, J Weiss.   

Abstract

The cell-free fluid (ascitic fluid, AF) of a sterile inflammatory peritoneal exudate elicited in rabbits is potently bactericidal for complement-resistant gram-negative as well as gram-positive bacterial species. This activity is absent in plasma. We now show that essentially all activity in AF against Staphylococcus aureus is attributable to a group II 14-kD phospholipase A2 (PLA2), previously purified from AF in this laboratory. Antistaphylococcal activity of purified PLA2 and of whole AF containing a corresponding amount of PLA2 was comparable and blocked by anti-AF-PLA2 serum. At concentrations present in AF (approximately 10 nM), AF PLA2 kills > 2 logs of 10(6) S. aureus/ml, including methicillin-resistant clinical isolates, and other species of gram-positive bacteria. Human group II PLA2 displays similar bactericidal activity toward S. aureus (LD90 approximately 1-5 nM), whereas 14-kD PLA2 from pig pancreas and snake venom are inactive even at micromolar doses. Bacterial killing by PLA2 requires Ca2+ and catalytic activity and is accompanied by bacterial phospholipolysis and disruption of the bacterial cell membrane and cell wall. These findings reveal that group II extracellular PLA2, the function of which at inflammatory sites has been unclear, is an extraordinarily potent endogenous antibiotic against S. aureus and other gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550843      PMCID: PMC507087          DOI: 10.1172/JCI118399

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Structure-function relationships of phospholipases. The anticoagulant region of phospholipases A2.

Authors:  R M Kini; H J Evans
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

Review 2.  Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.

Authors:  W Pruzanski; P Vadas; J Browning
Journal:  J Lipid Mediat       Date:  1993-11

Review 3.  Diversity of group types, regulation, and function of phospholipase A2.

Authors:  E A Dennis
Journal:  J Biol Chem       Date:  1994-05-06       Impact factor: 5.157

Review 4.  Mammalian non-pancreatic phospholipases A2.

Authors:  I Kudo; M Murakami; S Hara; K Inoue
Journal:  Biochim Biophys Acta       Date:  1993-11-03

Review 5.  Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus.

Authors:  W Fischer
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

Review 6.  Ubiquitous natural antibiotics.

Authors:  J E Gabay
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

7.  Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes.

Authors:  J Weiss; M Inada; P Elsbach; R M Crowl
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

8.  Determinants of the inhibitory action of purified 14-kDa phospholipases A2 on cell-free prothrombinase complex.

Authors:  M Inada; R M Crowl; A C Bekkers; H Verheij; J Weiss
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

9.  Are events after endotoxemia related to circulating phospholipase A2?

Authors:  A A Santos; J L Browning; M R Scheltinga; E A Lynch; E F Brown; P Lawton; E Chambers; I Dougas; C D Benjamin; C A Dinarello
Journal:  Ann Surg       Date:  1994-02       Impact factor: 12.969

10.  Secretion of group 2 phospholipase A2 by lacrimal glands.

Authors:  T J Nevalainen; H J Aho; H Peuravuori
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-02       Impact factor: 4.799

View more
  56 in total

Review 1.  How methicillin-resistant Staphylococcus aureus evade neutrophil killing.

Authors:  Mallary Greenlee-Wacker; Frank R DeLeo; William M Nauseef
Journal:  Curr Opin Hematol       Date:  2015-01       Impact factor: 3.284

2.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.

Authors:  L M Madsen; M Inada; J Weiss
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

Authors:  Hiroyasu Sato; Rina Kato; Yuki Isogai; Go-ichi Saka; Mitsuhiro Ohtsuki; Yoshitaka Taketomi; Kei Yamamoto; Kae Tsutsumi; Joe Yamada; Seiko Masuda; Yukio Ishikawa; Toshiharu Ishii; Tetsuyuki Kobayashi; Kazutaka Ikeda; Ryo Taguchi; Shinji Hatakeyama; Shuntaro Hara; Ichiro Kudo; Hiroyuki Itabe; Makoto Murakami
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

5.  Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins.

Authors:  A Panyutich; J Shi; P L Boutz; C Zhao; T Ganz
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 6.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

7.  Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears.

Authors:  X D Qu; R I Lehrer
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

8.  IL-25 improves luminal innate immunity and barrier function during parenteral nutrition.

Authors:  Aaron F Heneghan; Joseph F Pierre; Ankush Gosain; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

9.  Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3.

Authors:  Tomaz Koprivnjak; Christopher Weidenmaier; Andreas Peschel; Jerrold P Weiss
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

Review 10.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.